Severity of manifestations in tuberous sclerosis complex in relation to genotype

Epilepsia

Volumn 55, Issue 7, 2014, Pages 1025-1029

  Kothare, Sanjeev V ^a   Singh, Kanwaljit ^a,b   Chalifoux, Jason R ^a   Staley, Brigid A ^a   Weiner, Howard L ^a   Menzer, Kimberly ^a   Devinsky, Orrin ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Epilepsy; TSC mutations; Tuberous sclerosis complex

Indexed keywords

TUBERIN;

ABSENCE SEIZURE; ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; ATONIC SEIZURE; ATTENTION DEFICIT DISORDER; AUTISM; CHILD; CLONIC SEIZURE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DISEASE SEVERITY; EPILEPSY; FEBRILE CONVULSION; FEMALE; FOCAL EPILEPSY; GELASTIC SEIZURE; GENE; GENE MUTATION; GENERALIZED EPILEPSY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INFANT; INFANTILE SPASM; INTELLECTUAL IMPAIRMENT; LENNOX GASTAUT SYNDROME; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MYOCLONUS SEIZURE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SCHOOL CHILD; SEIZURE; SUBEPENDYMAL GIANT CELL ASTROCYTOMA; SUBEPENDYMOMA; TONIC CLONIC SEIZURE; TONIC SEIZURE; TUBEROUS SCLEROSIS; TUBEROUS SCLEROSIS COMPLEX 1 GENE; TUBEROUS SCLEROSIS COMPLEX 2 GENE; VERY ELDERLY; YOUNG ADULT;

EPILEPSY; TSC MUTATIONS; TUBEROUS SCLEROSIS COMPLEX;

ADOLESCENT; ADULT; BELGIUM; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; GENOTYPE; HUMANS; INFANT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS; UNITED STATES; YOUNG ADULT;

EID: 84904403492     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12680     Document Type: Article

References (20)

1. Crino PB, Nathanson KL, Henske EP,. The tuberous sclerosis complex. N Engl J Med 2006; 355: 1345-1356.
2. Webb DW, Fryer AE, Osborne JP,. Morbidity associated with tuberous sclerosis: a population study. Dev Med Child Neurol 1996; 38: 146-155.
3. Wong V,. Study of the relationship between tuberous sclerosis complex and autistic disorder. J Child Neurol 2006; 21: 199-204.
4. Numis AL, Major P, Montenegro MA, et al. Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex. Neurology 2011; 76: 981-987.
5. Goh S, Kwiatkowski DJ, Dorer DJ, et al. Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex. Neurology 2005; 65: 235-238.
6. ILAE. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981; 22: 489-501.
7. ILAE. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989; 30: 389-399.
8. Wu WE, Kirov II, Tal A, et al. Brain MR spectroscopic abnormalities in "MRI-negative" tuberous sclerosis complex patients. Epilepsy Behav 2013; 27: 319-325.
9. Berg AT, Plioplys S,. Epilepsy and autism: is there a special relationship? Epilepsy Behav 2012; 23: 193-198.
10. Tuchman R, Cuccaro M, Alessandri M,. Autism and epilepsy: historical perspective. Brain Dev 2010; 32: 709-718.
11. Spence SJ, Schneider MT,. The role of epilepsy and epileptiform EEGs in autism spectrum disorders. Pediatr Res 2009; 65: 599-606.
12. Chu-Shore CJ, Major P, Camposano S, et al. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 2010; 51: 1236-1241.
13. Dabora SL, Jozwiak S, Franz DN, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001; 68: 64-80.
14. Jansen FE, Braams O, Vincken KL, et al. Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations. Neurology 2008; 70: 908-915.
15. Jones AC, Daniells CE, Snell RG, et al. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum Mol Genet 1997; 6: 2155-2161.
16. Au KS, Williams AT, Roach ES, et al. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med 2007; 9: 88-100.
17. Plank TL, Yeung RS, Henske EP,. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res 1998; 58: 4766-4770.
18. Gutmann DH, Zhang Y, Hasbani MJ, et al. Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues. Acta Neuropathol 2000; 99: 223-230.
19. van Slegtenhorst M, Nellist M, Nagelkerken B, et al. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 1998; 7: 1053-1057.
20. Maheshwar MM, Cheadle JP, Jones AC, et al. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis. Hum Mol Genet 1997; 6: 1991-1996.